Palisade Bio (PALI) Current Assets (2010 - 2026)

Palisade Bio (PALI) has 17 years of Current Assets data on file, last reported at $133.2 million in Q1 2026.

• On a quarterly basis, Current Assets rose 1589.4% year-over-year to $133.2 million in Q1 2026; TTM through Mar 2026 was $133.2 million, a 1589.4% increase from a year earlier, with the FY2025 full-year figure at $134.2 million, up 1179.03% from the prior year.
• Current Assets for Q1 2026 stood at $133.2 million, down from $134.2 million in the prior quarter.
• Over the last five years, Current Assets for PALI reached as high as $134.2 million in Q4 2025 and fell as low as $6.4 million in Q2 2025.
• Historically, Current Assets has averaged $25.8 million across 5 years, with a median of $12.3 million in 2024.
• Across the five-year window, Current Assets slumped 49.64% in 2022 and surged 1589.4% in 2026, its largest moves.
• Year by year, Current Assets stood at $14.7 million in 2022, then retreated by 9.54% to $13.3 million in 2023, then slipped by 21.26% to $10.5 million in 2024, then soared by 1179.03% to $134.2 million in 2025, then decreased by 0.73% to $133.2 million in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $133.2 million in Q1 2026, $134.2 million in Q4 2025, and $6.8 million in Q3 2025.